Entrepreneurs News
Entrepreneurs in the News
- BRIDGEWATER, N.J., July 16, 2024 – JOGO Health Announces Collaboration With Mayo Clinic to Study Tremors
- Incubator at North Brunswick – New Jersey’s Largest Biotech Incubator
- TRENTON, N.J., February 15, 2024 – NJEDA to Hold Monthly Office Hours Highlighting Innovation Programs
- BARDA Announces New Partnerships to Treat Serious Outcomes of Infectious Disease
- January 22, 2024 – RizLab’s CytoTracker Provides Highly Accurate White Blood Cell Count with Single Drop of Blood
- NEW YORK, NY, January 8, 2024 – NYC’s ERA Announces Participants for its Winter 2023 Program; Companies Receive $150,000 Investments on a Post-Money Safe
- November 14, 2023 – SkunkWorx Bio Was Recently Awarded An STTR Grant From The NIH
- SAN DIEGO, CA, November 14, 2023 – MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative Antibody Drug Conjugate Candidates
- REHOVOT, Israel and MONMOUTH JUNCTION, N.J., November 06, 2023 – Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors
- BRIDGEWATER, N.J., November 1, 2023 – VYNE Therapeutics Announces Closing of Previously Announced Private Placement of $88.2 Million – VYNE Therapeutics
- FLEMINGTON, N.J., November 1, 2023 – EmphyCorp N115 Nonsteroidal Nasal Spray with no known side effects is treating Patients in a Phase III Clinical Trial for IPF (Coughing and Improved Lung Function)
- PRINCETON, N.J., Sept. 26, 2023 – Acasti Announces $7.5 Million Private Placement Equity Financing
- UNION, N.J., October 26, 2023 – ILSE Research Competition Winners
- PRINCETON, N.J., October 25, 2023 – Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
- PRINCETON, N.J., October, 24, 2023 – iQure Pharma secures $1.2M funding from Ventura BioMed and OKG Capital
- CRANBURY, N.J., October 23, 2023 – Palatin Announces $5 Million Registered Direct Offering
- October 19, 2023 – CMIC and Rutgers Link to Establish Manufacturing Excellence Center in the US
- SOUTH PLAINFIELD, N.J., October 19, 2023 – PTC Therapeutics Announces Evrysdi® Royalty Agreement With Royalty Pharma for Up to $1.5 Billion
- October 17, 2023 – Institute for Life Science Entrepreneurship Announces Winners of the $50,000 Translational Research Competition
- NORTH BRUNSWICK, N.J., October 16, 2023 – BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
- October 11, 2023 – Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia in Children
- NORTH BRUNSWICK, N.J, October 10, 2023 – Couragene Co-founders Developing Gene Editing Technology for Genetic Diseases Awarded Major Federal Grant
- October 9, 2023 – Postpartum Depression Digital Therapeutic Shows Positive Results in Clinical Trial
- October 04, 2023 – Hackensack Meridian Health Research Institute Creates First Spin-off Company, EValuate Diagnostics
- NEW YORK AND SHANGHAI, September 29, 2023 – O’Melveny Represents Adlai Nortye in Approximate US$100 Million Nasdaq IPO
- EDISON, N.J., Sept. 29, 2023 – Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
- UNION, N.J., September 27, 2023 – ILSE SBIR and STTR Winners
- FLORHAM PARK, N.J., September 26, 2023 – Phathom Pharmaceuticals Announces Vonoprazan NDA Submission for Non-Erosive GERD
- August 24, 2023 – Ascendia® Named to Inc. 5000 for Fourth Consecutive Year
- NEW YORK, N.Y., June 29, 2023 – Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with
- June 14, 2023 – Semper Paratus Acquisition Corporation Tech Trends: Woman-led SciMar ONE’s Drug Development Offering Evolves
- NEW YORK, N.Y., February 24, 2023 – Savvy Raises Seed Funding to Build the Next Generation Wealth Management Firm
- November 21, 2022 – Getting Start-Ups Started Faster
